1. P629 Real-life treatment persistence and treatment outcomes of Finnish patients with Inflammatory Bowel Disease receiving vedolizumab as first-line biological treatment. (30th January 2023) Authors: Ylisaukko-oja, T; Af Björkesten, C G; Erbel, A; Nuutinen, H; Jussila, A; Molander, P; Koskela, R; Blomster, T; Pajala, M; Ilus, T; Haiko, P; Kovac, B; Silvola, S; Smith, S; Jokelainen, J; Sipponen, T Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i758 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗